{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:17:06Z","timestamp":1787062626627,"version":"build-2736575974"},"update-to":[{"DOI":"10.1002\/14651858.cd006132.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T00:00:00Z","timestamp":1367280000000}}],"reference-count":142,"publisher":"Wiley","issue":"4","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006132.pub3","type":"journal-article","created":{"date-parts":[[2013,4,27]],"date-time":"2013-04-27T22:57:38Z","timestamp":1367103458000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Interventions for improving adherence to ocular hypotensive therapy"],"prefix":"10.1002","volume":"2013","author":[{"given":"Heather","family":"Waterman","sequence":"first","affiliation":[{"name":"University of Manchester; School of Nursing, Midwifery and Social Work; Room 6.31a, University Place Oxford Road Manchester UK M13 9PL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R","family":"Evans","sequence":"additional","affiliation":[{"name":"London School of Hygiene & Tropical Medicine; Cochrane Eyes and Vision Group, ICEH; Keppel Street London UK WC1E 7HT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trish A","family":"Gray","sequence":"additional","affiliation":[{"name":"Manchester Royal Eye Hospital; Academic Department of Ophthalmology; Oxford Road Manchester UK M13 9WH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Henson","sequence":"additional","affiliation":[{"name":"Manchester Royal Eye Hospital; Academic Department of Ophthalmology; Oxford Road Manchester UK M13 9WH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Harper","sequence":"additional","affiliation":[{"name":"Central Manchester & Manchester Children's NHS Trust; Optometry Department; Manchester Royal Eye Hospital Oxford Road Manchester UK M13 9WH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,4,30]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/eye.2011.269","article-title":"Individualised patient care as an adjunct to standard care for promoting adherence to ocular hypotensive therapy: an exploratory randomised controlled trial","volume":"26","author":"Gray","year":"2012","journal-title":"Eye"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0002|cit2","unstructured":"Henson D The impact of an individualised programme of care on persistence of and adherence to therapy in newly treated cases of glaucoma or ocular hypertension Ocular Health and Special Senses, North West Regional Office, ongoing"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0003|cit3","first-page":"300","article-title":"Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring","volume":"89","author":"Herman","year":"2011","journal-title":"Acta Ophthalmologica"},{"issue":"8","key":"10.1002\/14651858.CD006132.pub3-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/IJG.0b013e3181f3eb4a","article-title":"Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring","volume":"20","author":"Hermann","year":"2011","journal-title":"Journal of Glaucoma"},{"issue":"10","key":"10.1002\/14651858.CD006132.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1001\/archophthalmol.2012.1607","article-title":"Impact of a health communication intervention to improve glaucoma treatment adherence: results of the Interactive Study to Increase Glaucoma Adherence to Treatment Trial results of the I-SIGHT Trial","volume":"130","author":"Glanz","year":"2012","journal-title":"Archives of Ophthalmology"},{"issue":"5","key":"10.1002\/14651858.CD006132.pub3-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S0149-2918(96)80042-7","article-title":"Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life","volume":"18","author":"Laibovitz","year":"1996","journal-title":"Clinical Therapeutics"},{"issue":"11","key":"10.1002\/14651858.CD006132.pub3-BIB0007|cit7","first-page":"654","article-title":"The effect of a medication alarm device on patient compliance with topical pilocarpine","volume":"67","author":"Laster","year":"1996","journal-title":"Journal of the American Optometric Association"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.pec.2011.09.009","article-title":"The influence of health literacy level on an educational intervention to improve glaucoma medication adherence","volume":"87","author":"Muir","year":"2012","journal-title":"Patient Education and Counseling"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/OPTH.S29912","article-title":"Comparison of the latanoprost 0.005%\/ timolol 0.5% + brinzolamide 1% versus dorzolamide 1%\/ timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial","volume":"6","author":"Nakakura","year":"2012","journal-title":"Clinical Ophthalmology"},{"issue":"6197","key":"10.1002\/14651858.CD006132.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.2.6197.1031","article-title":"Improving medication compliance: a randomised clinical trial","volume":"2","author":"Norell","year":"1979","journal-title":"British Medical Journal"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0011|cit11","unstructured":"NCT00333463 Compliance with once daily glaucoma medication http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00333463"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0012|cit12","volume-title":"A Quasi Experimental Study of Adherence to Ocular Hypotensive Treatment: a Patient Education Perspective [MSc dissertation]","author":"Ring","year":"2011"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1089\/jop.2005.21.483","article-title":"Comparison of latanoprost monotherapy and combined therapy of 0.5% timolol and 1% dorzolamide in chronic primary angle-closure glaucoma (CACG) in Japanese patients","volume":"21","author":"Sakai","year":"2005","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0014|cit14","doi-asserted-by":"crossref","unstructured":"Schenker H Maloney S Liss C Gormley G Hartenbaum D Patient preference, efficacy, and compliance with timolol maleate ophthalmic gel-forming solution versus timolol maleate ophthalmic solution in patients with ocular hypertension or open-angle glaucoma Clinical Therapeutics 1999 138 47","DOI":"10.1016\/S0149-2918(00)88274-0"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0015|cit15","first-page":"15","article-title":"An evaluation of the effectiveness of a nurse-led glaucoma monitoring clinic","volume":"7","author":"Sheppard","year":"2003","journal-title":"Ophthalmic Nursing"},{"issue":"5","key":"10.1002\/14651858.CD006132.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00061198-199910000-00008","article-title":"The dorzolamide\/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group","volume":"8","author":"Sverrisson","year":"1999","journal-title":"Journal of Glaucoma"},{"issue":"5","key":"10.1002\/14651858.CD006132.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00061198-199910000-00008","article-title":"The dorzolamide\/timolol combination versus timolol plus pilocarpine: patient preference and impact on daily life. United States Patient Preference Study Group. International Patient Preference Study Group","volume":"8","author":"Sverrisson","year":"1999","journal-title":"Journal of Glaucoma"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Akafo SK Thompson JR Rosenthal AR A cross-over trial comparing once daily levobunolol with once and twice daily timolol European Journal of Ophthalmology 1995 172 6","DOI":"10.1177\/112067219500500305"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0019|cit19","doi-asserted-by":"crossref","unstructured":"Amon A Menapace R Wedrich A Radax U Aspects of glaucoma patient care and its impact on compliance Spektrum der Augenheilkunde 1990 5 8","DOI":"10.1007\/BF03163348"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1089\/jop.2004.20.470","article-title":"Two-year follow-up of latanoprost 0.005% monotherapy after changing from previous glaucoma therapies","volume":"20","author":"Bayer","year":"2004","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0021|cit21","doi-asserted-by":"crossref","unstructured":"Bhojwani SC Jones DK Comparative study of aqueous and oily pilocarpine in the production of ocular hypotension British Journal of Ophthalmology 1981 530 2","DOI":"10.1136\/bjo.65.8.530"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0022|cit22","first-page":"S417","article-title":"Subjective vs objective assessment of patient compliance with glaucoma medical therapy","volume":"42","author":"Blair","year":"2001","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0023|cit23","first-page":"U457","article-title":"Glaucoma and compliance: comparison of objective patient compliance information with respect to \"QD\" dosing versus \"BID\" dosing on patient medication compliance","volume":"45","author":"Blair","year":"2004","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0024|cit24","doi-asserted-by":"crossref","unstructured":"Bron A Velasque L Rebica H Pouliquen P Elena PP Rouland JF Comparison of once-daily nonpreserved timolol and timolol maleate gel-forming solution associated with latanoprost Journal Fran\u00e7ais d'Ophtalmologie 2004 971 7","DOI":"10.1016\/S0181-5512(04)96251-1"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0025|cit25","doi-asserted-by":"crossref","unstructured":"Chang JS Lee DA Petursson G Spaeth G Zimmerman TJ Hoskins HD The effect of a glaucoma medication reminder cap on patient compliance and intraocular pressure Journal of Ocular Pharmacology 1991 117 24","DOI":"10.1089\/jop.1991.7.117"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0161-6420(92)31957-8","article-title":"Once-daily versus twice-daily levobunolol (0.5%) therapy: a crossover study","volume":"99","author":"Derick","year":"1992","journal-title":"Ophthalmology"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0027|cit27","doi-asserted-by":"crossref","unstructured":"Dunker S Schmucker A Maier H. Latanoprost\/Timolol Fixed Combination Study Group Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol Advances in Therapy 2007 376 86","DOI":"10.1007\/BF02849907"},{"issue":"11","key":"10.1002\/14651858.CD006132.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.clinthera.2006.11.001","article-title":"Patients' and physicians' perceptions of the travoprost dosing aid: an open-label, multicenter study of adherence with prostaglandin analogue therapy for open-angle glaucoma or ocular hypertension","volume":"28","author":"Flowers","year":"2006","journal-title":"Clinical Therapeutics"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0029|cit29","first-page":"303","article-title":"Compliance and glaucoma: utility of a simplified therapy","volume":"75","author":"Ghinato","year":"1996","journal-title":"Bollettino D Oculistica"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0030|cit30","doi-asserted-by":"crossref","unstructured":"Goni FJ. Brimonidine\/Timolol Fixed Combination Study Group 12-week study comparing the fixed combination of brimonidine and timolol with concomitant use of the individual components in patients with glaucoma and ocular hypertension European Journal of Ophthalmology 2005 581 90","DOI":"10.1177\/112067210501500508"},{"issue":"7","key":"10.1002\/14651858.CD006132.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/bjo.66.7.464","article-title":"Glaucoma patients not compliant with their drug therapy: clinical and behavioral aspects","volume":"66","author":"Granstrom","year":"1982","journal-title":"British Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10792-011-9495-z","article-title":"Comparison of fixed combinations of dorzolamide\/timolol and brimonidine\/timolol in patients with primary open-angle glaucoma","volume":"31","author":"Gulkilik","year":"2011","journal-title":"International Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0033|cit33","first-page":"215","article-title":"Evaluation of topical brinzolamide switched from dorzolamide for glaucoma","volume":"59","author":"Hasegawa","year":"2005","journal-title":"Japanese Journal of Clinical Ophthalmology"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0034|cit34","doi-asserted-by":"crossref","unstructured":"Hughes BA Bacharach J Craven ER Kaback MB Mallick S Landry TA A three-month, multicenter, double-masked study of the safety and efficacy of travoprost 0.004%\/ timolol 0.5% ophthalmic solution compared to travoprost 0.004% ophthalmic solution and timolol 0.5% dosed concomitantly in subjects with open angle glaucoma or ocular hypertension Journal of Glaucoma 2005 392 9","DOI":"10.1097\/01.ijg.0000176935.08392.14"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0035|cit35","unstructured":"Hunter F Evaluation of compliance in patients with glaucoma National Research Register. NHS Lothian - University Hospitals Division 1999"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1089\/jop.2011.0057","article-title":"Ocular hypotensive effects and safety over 3 months of switching from an unfixed combination to latanoprost 0.005%\/timolol maleate 0.5% fixed combination","volume":"27","author":"Inoue","year":"2011","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/OPTH.S29062","article-title":"Ocular hypotensive effect and safety of travoprost 0.004%\/timolol maleate 0.5% fixed combination after change of treatment regimen from beta-blockers and prostaglandin analogs","volume":"6","author":"Inoue","year":"2012","journal-title":"Clinical Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(14)74225-4","article-title":"Compliance with topical timolol treatment","volume":"103","author":"Kass","year":"1987","journal-title":"American Journal of Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD006132.pub3-BIB0039|cit39","first-page":"426","article-title":"Canadian study of Travatan as replacement therapy (CSTART): switching to Travatan can improve long-term care","volume":"21","author":"Klein","year":"2003","journal-title":"Clinical and Surgical Ophthalmology"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0040|cit40","doi-asserted-by":"crossref","unstructured":"Konstas AG Lake S Maltezos AC Holmes KT Stewart WC Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma Eye 2001 59 62","DOI":"10.1038\/eye.2001.14"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0041|cit41","doi-asserted-by":"crossref","unstructured":"Kurtz S Shemesh G The efficacy and safety of once-daily versus once-weekly latanoprost treatment for increased intraocular pressure Journal of Ocular Pharmacology and Therapeutics 2004 321 7","DOI":"10.1089\/1080768041725353"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.2147\/OPTH.S25987","article-title":"Addition of a fixed combination of brinzolamide 1%\/timolol 0.5% to prostaglandin monotherapy in patients with glaucoma or ocular hypertension","volume":"5","author":"Lorenz","year":"2011","journal-title":"Clinical Ophthalmology"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0043|cit43","doi-asserted-by":"crossref","unstructured":"March WF Ochsner KI. Brinzolamide Long-Term Therapy Study Group The long-term safety and efficacy of brinzolamide 1.0% (Azopt) in patients with primary open-angle glaucoma or ocular hypertension American Journal of Ophthalmology 2000 136 43","DOI":"10.1016\/S0002-9394(99)00343-8"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0044|cit44","unstructured":"Determination of predictive factors allowing to an additional 10% reduction of intra-ocular pressure (PREDICOM) clinicaltrials.gov\/ct2\/show\/NCT00230763"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0045|cit45","unstructured":"NCT00262626 The Canadian glaucoma study clinicaltrials.gov\/ct2\/show\/NCT00262626"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0046|cit46","unstructured":"NCT00328835 Optic nerve compliance study clinicaltrials.gov\/ct2\/show\/study\/NCT00328835"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0047|cit47","unstructured":"NCT00329095 An evaluation of use of topical ocular hypotensive medication by compliance clinicaltrials.gov\/ct2\/show\/NCT00329095"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0048|cit48","unstructured":"NCT00348062 A multicenter evaluation of methods to reduce hyperemia associated with bimatoprost therapy for glaucoma or ocular hypertension clinicaltrials.gov\/ct2\/show\/NCT00348062"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0049|cit49","unstructured":"NCT01415401 Efficacy and tolerability of AZARGA\u00ae as replacement therapy in patients on COMBIGAN\u00ae therapy in Canada clinicaltrials.gov\/ct2\/show\/NCT01415401"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0050|cit50","doi-asserted-by":"crossref","unstructured":"Novack GD David R Lee PF Freeman MI Duzman E Batoosingh AL Effect of changing medication regimens in glaucoma patients Ophthalmologica 1988 23 8","DOI":"10.1159\/000309870"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"28","DOI":"10.5301\/ejo.5000006","article-title":"Timogel(R) vs timolol 0.5% ophthalmic solution: efficacy, safety, and acceptance","volume":"22","author":"Rolle","year":"2012","journal-title":"European Journal of Ophthalmology"},{"issue":"16","key":"10.1002\/14651858.CD006132.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1517\/14656566.2011.589384","article-title":"From dorzolamide 2%\/timolol 0.5% to brinzolamide 1%\/timolol 0.5% fixed combination: a 6-month, multicenter, open-label tolerability switch study","volume":"12","author":"Rossi","year":"2011","journal-title":"Expert Opinion on Pharmacotherapy"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0053|cit53","first-page":"282","article-title":"The influence of the Travalert (R) dosing aid on medical treatment compliance and the quality of life of glaucoma patients","volume":"86","author":"Sanchez-Pulgarin","year":"2011","journal-title":"Archivos de la Sociedad Espanola de Oftalmologia"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0054|cit54","first-page":"396","article-title":"Effectiveness of the C Cap in promoting prescription refill compliance among patients with glaucoma","volume":"13","author":"Sclar","year":"1991","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0055|cit55","doi-asserted-by":"crossref","unstructured":"Shibuya T Kashiwagi K Tsukahara S Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension Ophthalmologica 2003 31 8","DOI":"10.1159\/000068248"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0002-9394(86)90823-8","article-title":"Glaucoma treatment with once-daily levobunolol","volume":"101","author":"Wandel","year":"1986","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0057|cit57","first-page":"77","article-title":"Clinical observation on the effect of 4% pilocarpine gel used one dose per day in the treatment of glaucoma","volume":"16","author":"Yie","year":"2000","journal-title":"Yen Ko Hsueh Pao [Eye Science]"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0058|cit58","unstructured":"ISRCTN25754048 Glaucoma compliance aids research project controlled-trials.com\/ISRCTN25754048\/"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0059|cit59","unstructured":"ISRCTN31673586 Comparing the after-use sensation and safety of long acting (LA) carteolol 2 % versus timolol LA 0.5 % in simple intra-ocular hypertension and glaucoma controlled-trials.com\/ISRCTN31673586\/"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0060|cit60","unstructured":"ISRCTN89683704 Helping adherence with glaucoma treatment: a randomised trial controlled-trials.com\/ISRCTN89683704\/"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0061|cit61","unstructured":"NCT00376974 The effect of education on patient compliance clinicaltrials.gov\/ct2\/show\/NCT00376974"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0062|cit62","unstructured":"NCT00454922 Effect of glaucoma educators on adherence to prescribed therapeutic regimens in glaucoma patients clinicaltrials.gov\/ct2\/show\/NCT00454922"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0063|cit63","unstructured":"NCT00465803 A phase IIIb study of DuoTrav to treat glaucoma or ocular hypertension clinicaltrials.gov\/ct2\/show\/NCT00465803"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0064|cit64","unstructured":"NCT00508469 Adherence assessment with Travalert dosing aid clinicaltrials.gov\/ct2\/show\/NCT00508469"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0065|cit65","unstructured":"NCT00573638 Effects of Xal-Ease on patient compliance with Xalatan clinicaltrials.gov\/ct2\/show\/NCT00573638"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0066|cit66","unstructured":"NCT00626067 Study of patient use and perception of the Travatan dosing aid clinicaltrials.gov\/ct2\/show\/NCT00626067"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0067|cit67","unstructured":"NCT00676637 Glaucoma Adherence Study (GAS) clinicaltrials.gov\/ct2\/show\/NCT00676637"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0068|cit68","unstructured":"NCT00756184 Value of an intervention to enhance adherence in glaucoma patients clinicaltrials.gov\/ct2\/show\/NCT00756184"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0069|cit69","unstructured":"NCT00767793 A placebo-controlled study of INS117548 ophthalmic solution in subjects with glaucoma clinicaltrials.gov\/ct2\/show\/NCT00767793"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0070|cit70","unstructured":"NCT00887029 A 12 week comparison of DuoTrav and Xalacom in open-angle glaucoma (DVX) clinicaltrials.gov\/ct2\/show\/NCT00887029"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0071|cit71","unstructured":"NCT01125306 Efficiency of Xal-Ease device in glaucoma and\/or ocular hypertension (OHT) patients, treated with Xalatan or Xalacom clinicaltrials.gov\/ct2\/show\/NCT01125306"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0072|cit72","unstructured":"NCT01409421 Glaucoma treatment adherence and persistence clinicaltrials.gov\/ct2\/show\/NCT01409421"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0073|cit73","unstructured":"NCT01417689 Eyedrop instillation technique clinicaltrials.gov\/ct2\/show\/NCT01417689"},{"issue":"8","key":"10.1002\/14651858.CD006132.pub3-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/eye.2010.27","article-title":"Patterns and rate of adherence to glaucoma therapy using an electronic dosing aid","volume":"24","author":"Ajit","year":"2010","journal-title":"Eye"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0161-6420(97)30314-5","article-title":"Validation of a questionnaire for comparing the tolerability of ophthalmic medications","volume":"104","author":"Barber","year":"1997","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0277-9536(03)00259-4","article-title":"From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions","volume":"58","author":"Bissell","year":"2004","journal-title":"Social Science and Medicine"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/01.ijg.0000196654.77836.61","article-title":"Accuracy of an electronic monitoring and reminder device for use with travoprost eye drops","volume":"15","author":"Boden","year":"2006","journal-title":"Journal of Glaucoma"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0002-9149(97)00303-2","article-title":"Moderate dose, three-drug therapy with niacin, lovastatin, and colestipol to reduce low-density lipoprotein cholesterol <100 mg\/dl in patients with hyperlipidemia and coronary artery disease","volume":"80","author":"Brown","year":"1997","journal-title":"American Journal of Cardiology"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004399.pub3","article-title":"Medical versus surgical interventions for open angle glaucoma","author":"Burr","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1475-1313.2003.00155.x","article-title":"Chronic open angle glaucoma: patient awareness of the nature of the disease, topical medication, compliance and the prevalence of systemic symptoms","volume":"24","author":"Deokule","year":"2004","journal-title":"Ophthalmic and Physiological Optics"},{"issue":"8965","key":"10.1002\/14651858.CD006132.pub3-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/S0140-6736(95)90116-7","article-title":"Avoiding unsuspected respiratory side-effects of topical timolol with cardioselective or sympathomimetic agents","volume":"345","author":"Diggory","year":"1995","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1037\/1040-3590.5.1.102","article-title":"Patient adherence to cancer control regimens: scale development and initial validation","volume":"5","author":"DiMatteo","year":"1993","journal-title":"Psychological Assessment"},{"issue":"8","key":"10.1002\/14651858.CD006132.pub3-BIB0083|cit83","first-page":"e3081","article-title":"Systematic review of the empirical evidence of study publication bias and outcome reporting bias","volume":"3","author":"Dwan","year":"2008","journal-title":"PLoS Hub for Clinical Trials"},{"issue":"10","key":"10.1002\/14651858.CD006132.pub3-BIB0084|cit84","first-page":"2251","article-title":"Risk factors for late presentation in chronic glaucoma","volume":"40","author":"Fraser","year":"1999","journal-title":"Investigative Ophthalmology and Visual Science"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ajo.2006.11.036","article-title":"The Travatan dosing aid accurately records when drops are taken","volume":"143","author":"Friedman","year":"2007","journal-title":"American Journal of Ophthalmology"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0086|cit86","first-page":"130","article-title":"How to identify randomized controlled trials in MEDLINE: ten years on","volume":"94","author":"Glanville","year":"2006","journal-title":"Journal of the Medical Library Association"},{"issue":"7650","key":"10.1002\/14651858.CD006132.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"12","key":"10.1002\/14651858.CD006132.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1038\/eye.2010.121","article-title":"Preliminary survey of educational support for patients prescribed ocular hypotensive therapy","volume":"24","author":"Gray","year":"2010","journal-title":"Eye"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0089|cit89","volume-title":"Compliance in Healthcare","author":"Haynes","year":"1979"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0090|cit90","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000011.pub3","article-title":"Interventions for enhancing medication adherence","author":"Haynes","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD006132.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Archives of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10792-010-9362-3","article-title":"Electronic monitoring of topical treatment after ophthalmic surgery","volume":"30","author":"Hermann","year":"2010","journal-title":"International Ophthalmology"},{"issue":"7","key":"10.1002\/14651858.CD006132.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/bjo.2005.088526","article-title":"Microprocessor controlled compliance monitor for eye drop medication","volume":"90","author":"Hermann","year":"2006","journal-title":"British Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0094|cit94","article-title":"Chapter 8: Assessing risk of bias in included studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychology and Health"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006132.pub3-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"65S","DOI":"10.1378\/chest.130.1_suppl.65S","article-title":"Compliance, adherence, and concordance: implications for asthma treatment","volume":"130","author":"Horne","year":"2006","journal-title":"Chest"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/fampra\/15.2.165","article-title":"A comparison of a Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations","volume":"15","author":"Howie","year":"1998","journal-title":"Family Practice"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/sj.eye.6700036","article-title":"Quality of life in patients with early, moderate and advanced glaucoma","volume":"16","author":"Iester","year":"2002","journal-title":"Eye"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3129\/i08-076","article-title":"Mulitcenter study of compliance and drop administration in glaucoma","volume":"43","author":"Kholdebarin","year":"2008","journal-title":"Canadian Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/eye.2008.103","article-title":"Barriers to adherence with glaucoma medications: a qualitative research study","volume":"23","author":"Lacey","year":"2009","journal-title":"Eye"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.socscimed.2006.06.003","article-title":"Outpatient process quality evaluation and the Hawthorne effect","volume":"63","author":"Leonard","year":"2006","journal-title":"Social Science and Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jhealeco.2007.07.004","article-title":"Is patient satisfaction sensitive to changes in the quality of care? An exploitation of the Hawthorne effect","volume":"27","author":"Leonard","year":"2008","journal-title":"Journal of Health Economics"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0103|cit103","first-page":"568","article-title":"Use of glaucoma medications: state of the science and directions for observational research","volume":"550","author":"Lu","year":"2010","journal-title":"American Journal of Ophthalmology"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1471-6712.2009.00739.x","article-title":"The views of compliant glaucoma patients on counselling and support","volume":"24","author":"Lunnela","year":"2010","journal-title":"Scandinavian Journal of Caring Science"},{"issue":"7509","key":"10.1002\/14651858.CD006132.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1136\/bmj.38506.594977.E0","article-title":"Treatment of ocular hypertension and open angle glaucoma: meta-analysis of randomised controlled trials","volume":"331","author":"Maier","year":"2005","journal-title":"BMJ"},{"issue":"7","key":"10.1002\/14651858.CD006132.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","article-title":"Development of the 25-Item National Eye Institute Visual Function Questionnaire","volume":"119","author":"Mangione","year":"2001","journal-title":"Archives of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1111\/1475-6773.10482","article-title":"An observational study of antibiotic prescribing behavior and the Hawthorne effect","volume":"37","author":"Mangione-Smith","year":"2002","journal-title":"Health Services Research"},{"issue":"1","key":"10.1002\/14651858.CD006132.pub3-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870440290001494","article-title":"The revised IIlness Perception Questionnaire (IPQ-R)","volume":"17","author":"Moss-Morris","year":"2002","journal-title":"Psychology and Health"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"487","DOI":"10.5694\/j.1326-5377.2006.tb00662.x","article-title":"Self-reported adherence with medication and cardiovascular disease outcomes in the Second Australian National Blood Pressure Study (ANBP2)","volume":"185","author":"Nelson","year":"2006","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0110|cit110","unstructured":"NICE Glaucoma: diagnosis and management of chronic open angle glaucoma and ocular hypertension www.nice.org.uk\/nicemedia\/live\/12145\/43839\/43839.pdf"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/j.1442-9071.2009.02184.x","article-title":"Readability of prescription labels and medication refill in a population of tertiary referral glaucoma patients","volume":"37","author":"O'Hare","year":"2009","journal-title":"Clinical and Experimental Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ophtha.2004.12.035","article-title":"Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review","volume":"112","author":"Olthoff","year":"2005","journal-title":"Ophthalmology"},{"issue":"10","key":"10.1002\/14651858.CD006132.pub3-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/BF02640361","article-title":"The test of functional health literacy in adults: a new instrument for measuring patients' literacy skills","volume":"10","author":"Parker","year":"1995","journal-title":"Journal of General Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0114|cit114","first-page":"233","article-title":"Compliance in patients prescribed eyedrops for glaucoma","volume":"26","author":"Patel","year":"1995","journal-title":"Ophthalmic Surgery"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"British Journal of Ophthalmology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006132.pub3-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajo.2003.10.035","article-title":"Patient persistency with topical ocular hypotensive therapy in a managed care population","volume":"137","author":"Reardon","year":"2004","journal-title":"American Journal of Ophthalmology"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0117|cit117","first-page":"451","article-title":"Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension:\u00a0a systematic review","volume":"5","author":"Reardon","year":"2011","journal-title":"Patient Preference and Adherence"},{"issue":"7145","key":"10.1002\/14651858.CD006132.pub3-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1136\/bmj.316.7145.1643","article-title":"Prevalence of serious eye disease and visual impairment in a north London population: population based, cross sectional study","volume":"316","author":"Reidy","year":"1998","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0119|cit119","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.jhh.1001721","article-title":"Patient compliance in hypertension: role of illness perceptions and treatment beliefs","volume":"18","author":"Ross","year":"2004","journal-title":"Journal of Human Hypertension"},{"issue":"Pt 2","key":"10.1002\/14651858.CD006132.pub3-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/eye.1998.56","article-title":"Compliance with timolol treatment in glaucoma","volume":"12","author":"Rotchford","year":"1998","journal-title":"Eye"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0122|cit122","unstructured":"Royal Pharmaceutical Society of Great Britain From compliance to concordance: achieving shared goals in medicine taking London RPS 1997"},{"issue":"10","key":"10.1002\/14651858.CD006132.pub3-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1167\/iovs.06-0299","article-title":"Variations in primary open angle glaucoma prevalence by age, gender and race: a Bayesian meta-analysis","volume":"47","author":"Rudnicka","year":"2006","journal-title":"Investigative Ophthalmology and Visual Science"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD006132.pub3-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1038\/eye.2008.337","article-title":"An assessment of readiness for behaviour change in patients prescribed ocular hypotensive therapy","volume":"23","author":"Schwartz","year":"2009","journal-title":"Eye"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0126|cit126","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10557-004-6225-z","article-title":"Self-reported adherence to cholesterol-lowering medication in patients with familial hypercholesterolaemia: the role of illness perceptions","volume":"18","author":"Senior","year":"2004","journal-title":"Cardiovascular Drugs and Therapy"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1136\/bjo.2010.199851","article-title":"Validation of a short version of the glaucoma self-efficacy questionnaire\u00a0","volume":"96","author":"Sleath","year":"2012","journal-title":"British Journal of Ophthalmology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006132.pub3-BIB0128|cit128","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajo.2005.07.075","article-title":"Evaluation of quality of life for patients with glaucoma","volume":"141","author":"Spaeth","year":"2006","journal-title":"American Journal of Ophthalmology"},{"issue":"6","key":"10.1002\/14651858.CD006132.pub3-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/sj.eye.6701605","article-title":"Risk factors for progressive visual field loss in primary open angle glaucoma","volume":"19","author":"Spry","year":"2005","journal-title":"Eye"},{"issue":"5","key":"10.1002\/14651858.CD006132.pub3-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1089\/10807680260362687","article-title":"Causes of non-compliance with drug regimes in glaucoma patients: a qualitative study","volume":"18","author":"Taylor","year":"2002","journal-title":"Journal of Ocular Pharmacology and Therapeutics"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/13548500410001721909","article-title":"Medication adherence in rheumatoid arthritis: effects of psychosocial factors","volume":"9","author":"Treharne","year":"2004","journal-title":"Psychology, Health and Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006132.pub3-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/00061198-200310000-00001","article-title":"Compliance barriers in glaucoma: a systematic classification","volume":"12","author":"Tsai","year":"2003","journal-title":"Journal of Glaucoma"},{"issue":"9","key":"10.1002\/14651858.CD006132.pub3-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1080\/02770900600925569","article-title":"The patient's perspective: adherence or non-adherence to asthma controller therapy?","volume":"43","author":"Ulrik","year":"2006","journal-title":"Journal of Asthma"},{"issue":"3","key":"10.1002\/14651858.CD006132.pub3-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00019053-199915030-00002","article-title":"Pharmacoeconomic consequences of variable patient compliance with prescribed drug regimens","volume":"15","author":"Urquhart","year":"1999","journal-title":"Pharmacoeconomics"},{"key":"10.1002\/14651858.CD006132.pub3-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1472-6963-7-55","article-title":"Patient adherence to medical treatment: a review of reviews","volume":"7","author":"Dulmen","year":"2007","journal-title":"BMC Health Services Research"},{"issue":"11","key":"10.1002\/14651858.CD006132.pub3-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1016\/j.clinthera.2009.11.028","article-title":"The role of patient inexperience in medication discontinuation: a retrospective analysis of medication non-persistence in seven chronic diseases","volume":"31","author":"Vanelli","year":"2009","journal-title":"Clinical Therapeutics"},{"issue":"5","key":"10.1002\/14651858.CD006132.pub3-BIB0137|cit137","first-page":"691","article-title":"A new taxonomy for describing and defining adherence to medication","volume":"73","author":"Vrijens","year":"2012","journal-title":"British Journal of Pharmacology"},{"issue":"7270","key":"10.1002\/14651858.CD006132.pub3-BIB0138|cit138","first-page":"493","article-title":"What is concordance?","volume":"271","author":"Weis","year":"2003","journal-title":"Pharmaceutical Journal"},{"issue":"1-3","key":"10.1002\/14651858.CD006132.pub3-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pec.2005.12.010","article-title":"Determinants of poor adherence in hypertensive patients: development and validation of the \"Maastricht Utrecht Adherence in Hypertension (MUAH)-questionnaire\"","volume":"64","author":"Wetzels","year":"2006","journal-title":"Patient Education and Counseling"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006132.pub3-BIB0140|cit140","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1016\/j.ajo.2005.09.011","article-title":"Measurement of persistence and adherence to regimens of IOP-lowering glaucoma medications using pharmacy claims data","volume":"141","author":"Wilensky","year":"2006","journal-title":"American Journal of Ophthalmology"},{"issue":"4","key":"10.1002\/14651858.CD006132.pub3-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1524-4733.2005.00041.x","article-title":"Persistence and adherence of medications for chronic overactive bladder\/urinary incontinence in the California medicaid program","volume":"8","author":"Yu","year":"2005","journal-title":"Value Health"},{"issue":"2","key":"10.1002\/14651858.CD006132.pub3-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006132.pub2","article-title":"Interventions for improving adherence to ocular hypotensive therapy","author":"Gray","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD006132.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T19:04:42Z","timestamp":1732475082000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD006132.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Eyes and Vision Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,30]]},"references-count":142,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006132.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,30]]}}}